These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32719683)

  • 1. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.
    Saldanha-Araujo F; Melgaço Garcez E; Silva-Carvalho AE; Carvalho JL
    Front Immunol; 2020; 11():1563. PubMed ID: 32719683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
    Golchin A; Seyedjafari E; Ardeshirylajimi A
    Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.
    Zumla A; Wang FS; Ippolito G; Petrosillo N; Agrati C; Azhar EI; Chang C; El-Kafrawy SA; Osman M; Zitvogel L; Galle PR; Locatelli F; Gorman E; Cordon-Cardo C; O'Kane C; McAuley D; Maeurer M
    Int J Infect Dis; 2020 Jul; 96():431-439. PubMed ID: 32425638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
    Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
    Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
    O'Driscoll L
    Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell-Based Therapy for Coronavirus Disease 2019.
    Zhao RC
    Stem Cells Dev; 2020 Jun; 29(11):679-681. PubMed ID: 32292113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
    Shi X; Yu L; Ding C
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report.
    Peng H; Gong T; Huang X; Sun X; Luo H; Wang W; Luo J; Luo B; Chen Y; Wang X; Long H; Mei H; Li C; Dai Y; Li H
    Stem Cell Res Ther; 2020 Jul; 11(1):291. PubMed ID: 32678017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Free Therapies: Novel Approaches for COVID-19.
    Maron-Gutierrez T; Rocco PRM
    Front Immunol; 2020; 11():583017. PubMed ID: 33072130
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
    Mansourabadi AH; Sadeghalvad M; Mohammadi-Motlagh HR; Rezaei N
    Life Sci; 2020 Oct; 258():118185. PubMed ID: 32750438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back to the spring of 2020: facts and hope of COVID-19 outbreak.
    Zhou G; Chen S; Chen Z
    Front Med; 2020 Apr; 14(2):113-116. PubMed ID: 32172487
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.
    Li C; Zhao H; Wang B
    Drug Des Devel Ther; 2020; 14():3995-4001. PubMed ID: 33061304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.